Insights

Gathering insights about MEDS…

Similar companies to MEDS

MEDS Tech Stack

MEDS uses 8 technology products and services including Disqus, MySQL, Mailchimp, and more. Explore MEDS's tech stack below.

Disqus
Comment Systems
MySQL
Database
Mailchimp
Email
PHP
Programming Languages
Yoast SEO
Search Engines
Google Tag Manager
Tag Management
Microsoft IIS
Web Servers
Facebook
Widgets

Media & News

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced the closing of its previously announced $100 million private investment in public equity (PIPE) financing. This substantial investment reinforces the Company's financial position and propels its late-stage non-opioid therapeutic programs toward key clinical and regulatory milestones. The financing also facilitates the integration of MindWave Innovations Inc., aligning corporate operations and.
Dec 10, 2025 | www.businesswire.com
Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
MATAWAN, N.J.--(BUSINESS WIRE)--(NYSE American: APUS) Apimeds Pharmaceuticals US, Inc. (“Apimeds”), a clinical-stage biotechnology company that completed its IPO in May 2025, today announced that it has merged with MindWave Innovations Inc (“MindWave”; the transaction, the “Merger”). Today, Apimeds and MindWave signed the merger agreement (the “Merger Agreement”) outlining the terms of the Merger, thus paving the way for a dual-growth enterprise spanning advanced biotechnology and institutional.
Dec 01, 2025 | www.businesswire.com
Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
MATAWAN, N.J. & MOSCOW, Idaho--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Futures Lab™ program through a new collaboration with the University of Idaho College of Business and Economics, beginning in the Spring 2026 semester. The initiative connects student teams with real-world biopharma business development projects, reinforcing Apimeds' commitment to fostering innovation, leadership, and discovery across the he.
Nov 10, 2025 | www.businesswire.com
Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business
MATAWAN, N.J. & EUGENE, Ore.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (“Apimeds”) today announced the expansion of the Apimeds ai² Futures Lab program through a new collaboration with the University of Oregon's Lundquist College of Business, starting with the Winter 2026 quarter. The initiative connects student teams with real-world biopharma business development projects, reinforcing Apimeds' commitment to fostering innovation, leadership, and discovery across the health.
Oct 14, 2025 | www.businesswire.com
Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the University of San Diego's Knauss School of Business. The initiative is designed to identify promising pharmaceutical assets critical to improving human health while cultivating the next generation of business leaders for the biopharmaceutical industry. Future Labs is part of Apimeds' ai² innovation.
Sep 15, 2025 | www.businesswire.com
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) today welcomed the U.S. Food and Drug Administration's (FDA) newly released draft guidance on the development of non-opioid pain therapies, highlighting its potential to accelerate the company's lead program, Apitox, for chronic osteoarthritis pain. The draft guidance, entitled “Development of Non-Opioid Analgesics for Chronic Pain, Draft Guidance for Industry”, can be found here: https://www.fda.gov/regulatory-inform.
Sep 11, 2025 | www.businesswire.com
Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of Alabama Culverhouse College of Business's STEM Path to the MBA program. The initiative aims to identify important assets critical to improving human health and to cultivate the next generation of pharmaceutical industry business leaders. Future Labs is part of Apimeds' ai² innovation platform, connectin.
Aug 25, 2025 | www.businesswire.com

MEDS's Email Address Formats

MEDS uses at least 1 format(s):

MEDS Email Formats	Example	Percentage
First.Last@er-meds.com	John.Doe@er-meds.com	49%
First.Middle@er-meds.com	John.Michael@er-meds.com	1%
First.Last@er-meds.com	John.Doe@er-meds.com	49%
First.Middle@er-meds.com	John.Michael@er-meds.com	1%

Frequently Asked Questions

What is MEDS's phone number?

You can contact MEDS's main corporate office by phone at

+1-618-624-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MEDS's stock symbol?

MEDS is a publicly traded company; the company's stock symbol is APUS.

What is MEDS's official website and social media links?

MEDS's official website is er-meds.com and has social profiles on LinkedIn.

What is MEDS's NAICS code?

MEDS's NAICS code is 62 - Health Care and Social Assistance.

How many employees does MEDS have currently?

As of December 2025, MEDS has approximately 144 employees across 5 continents, including North AmericaSouth AmericaAfrica. Key team members include Ceo: J. T.Chief Medical Officer: M. T.Chief Financial Officer: J. C.. Explore MEDS's employee directory with LeadIQ.

What industry does MEDS belong to?

MEDS operates in the Hospitals and Health Care industry.

What technology does MEDS use?

MEDS's tech stack includes DisqusMySQLMailchimpPHPYoast SEOGoogle Tag ManagerMicrosoft IISFacebook.

What is MEDS's email format?

MEDS's email format typically follows the pattern of First.Last@er-meds.com. Find more MEDS email formats with LeadIQ.

When was MEDS founded?

MEDS was founded in 1983.

MEDS

Q: What is MEDS's official website and social media links?

MEDS's official website is er-meds.com. MEDS has social profiles on LinkedIn.

Q: How many employees does MEDS have currently?

MEDS has approximately 144 employees.

Q: What technology does MEDS use?

MEDS's tech stack includes Facebook, Google Tag Manager, WordPress, MailChimp for WordPress, reCAPTCHA.

Hospitals and Health CareIllinois, United States51-200 Employees

MEDS, Midwest Emergency Department Services, provides staffing and management solutions that optimize emergency department performance. Our commitment to high-quality care plus our deep expertise in emergency medicine helps us build lasting relationships with clients and physicians. Hospitals and physicians who choose MEDS stay with MEDS because we’re accessible, responsive, and committed to their success.

Company Overview

Phone number: +1-618-624-****
Website: er-meds.com
Stock Symbol: APUS
NAICS Code: 62 - Health Care and Social Assistance
Founded: 1983
Employees: 51-200

Media & News

Funding & Financials

$25M$50M
MEDS's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$25M$50M
MEDS's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to MEDS

LYKO

Apoteket AB

Medstop Apotek

Yves Rocher

Apotek Hjärtat

MEDS Tech Stack

Media & News

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development

Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program

Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs

MEDS's Email Address Formats

Frequently Asked Questions

What is MEDS's phone number?

What is MEDS's stock symbol?

What is MEDS's official website and social media links?

What is MEDS's NAICS code?

How many employees does MEDS have currently?

What industry does MEDS belong to?

What technology does MEDS use?

What is MEDS's email format?

When was MEDS founded?

MEDS

Company Overview

Media & News

Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy

Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE

Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?